Search

Your search keyword '"Pan, Xiao Yan"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Pan, Xiao Yan" Remove constraint Author: "Pan, Xiao Yan"
154 results on '"Pan, Xiao Yan"'

Search Results

3. Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both

11. Global multi-stakeholder endorsement of the MAFLD definition

12. Global multi-stakeholder endorsement of the MAFLD definition

13. Ecological risk assessment of salinization in coastal plain based on SDI correction index

21. PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease

23. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease

24. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.

25. Circulating Neutrophil-Derived Microparticles Associated with the Prognosis of Patients with Sepsis

27. Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD

29. Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD

31. FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease

33. A combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels

34. Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease

36. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels

38. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease

39. PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels

41. FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease.

42. [Pilot study on comprehensive malaria control in Judong Village, Congjiang County, Guizhou Province]

44. PS-201-External validation in NAFLD cohorts of the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST to identify patients with active NASH (NAS ≥ 4) and significant fibrosis (F ≥ 2)

46. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.

48. PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.

Catalog

Books, media, physical & digital resources